Juno Therapeutics
Seattle · Founded 2013
About Juno Therapeutics
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Company Facts
- Founded: 2013
- Legal name: Juno Therapeutics, Inc.
- Operating status: Acquired
- Company type: For Profit
- IPO status: Delisted
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $310.0M
- Funding stage: M&A
- Last round: Series B (Aug 2014)
- Ticker: nasdaq:JUNO
- Website: http://junotherapeutics.com
- Phone: +1 206-696-0703
Investment Activity
- 2 exit(s) (2 via IPO)
Social Profiles
Canonical: https://fsome.com/organization/juno-therapeutics-8344159 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.